MedTrace Logo

Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study

NCT01776060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-05-21

No results posted yet for this study

Summary

The goal of this study is to enroll 100 participants with Primary Progressive Multiple Sclerosis (PPMS) that have joined the MURDOCK Study Horizon 1.5 (Duke IRB Pro00011196) and the Multiple Sclerosis cohort (Duke IRB Pro00023791). All 100 participants will complete a biannual collection of a follow up questionnaire and blood/urine collection for a period of 5 years.

Conditions

Interventions

OTHER

generation of 'omic markers of disease progression

Aside from first in disease sampling, the serial, biannual collection of samples from PPMS patients would not only permit the identification of 'omic profiles that can be compared and contrasted to those from RRMS patients in a parallel study, but it would also allow the generation of 'omic markers of disease progression.

Sponsors & Collaborators

Principal Investigators

  • Simon Gr, PhD · Duke Medicine Site Based Research Group

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2020-09-21
Completion
2020-09-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01776060 on ClinicalTrials.gov